{"data":{"id":"us-in/ic-25-26-16.5-10","jurisdiction":"us-in","citation":"IC 25-26-16.5-10","heading":"Basis and review of protocol","body":"Sec. 10. (a) A protocol of a health facility developed under this chapter must be:\n(1) based on clinical considerations; and\n(2) reviewed by the health facility's drug regimen committee at least quarterly.\n(b) A protocol of a health facility developed under this chapter may not:\n(1) prohibit the attending physician from approving only specific parts of a protocol; or\n(2) provide for an adjustment to an individual's drug regimen for the sole purpose of achieving a higher reimbursement for the substituted drug therapy than what would have been received for the original drug therapy ordered by the attending physician.","path":["TITLE 25. PROFESSIONS AND OCCUPATIONS","ARTICLE 26. PHARMACISTS, PHARMACIES, DRUG STORES","Chapter 16.5. Drug Regimens in Health Facilities"],"source_url":"https://iga.in.gov/ic/2026/Title_25.html#25-26-16.5-10","current_through":"2026","vintage":"2026","retrieved_at":"2026-10-06T20:43:28Z","sha256":"215b9d838b9637eb9d162646e4eb39ef80bfd47ffd3ff648205a1e3f8dd57da5","source_id":"us-in","stale":false,"prev":"us-in/ic-25-26-16.5-9","next":"us-in/ic-25-26-16.5-11"},"notice":"GroundRules: Original legal text. Not legal advice."}